Circulating tumour cells (CTCs) are rare yet crucial biomarkers with significant prognostic potential across different cancer types. However, their role in high-grade serous ovarian cancer (HSGC) is ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...
Jonathan Kotula: We think there needs to be a systems-level approach to deal with complex diseases such as cancer. A lot of what has been done so far are reductionist approaches—one small molecule for ...
Generation Bio announces new programs using ctLNP for targeted siRNA delivery in T cell-driven autoimmune diseases, aiming for IND submission in 2026. Development of novel siRNA therapeutics using ...
Expansion Microscopy (ExM) is an innovative and cost-effective super-resolution microscopy technique that has become popular in cell biology research. It achieves super-resolution by physically ...
Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand identity which bridges nearly 30 years of scientific leadership in the ...
One of ANSTO's advanced imaging instruments Dingo now delivers a rare fusion of simulation and radiobiology, becoming a launchpad for an innovative neutron therapy innovation. This unique scientific ...
Orca Bio CEO Nate Fernhoff, Ph.D., said the FDA's questions are not about Orca-T's clinical data. (iStock / Getty Images Plus) The FDA has delayed its target decision date for Orca Bio’s blood cancer ...
Deep inside a small, windowless room at the University of California, Berkeley, two microscopes are quietly capturing some of ...
Researchers are cultivating human brain cells in laboratories to transform them into biological circuits for supercomputers—a field known as “bio computing.” While it sounds like science fiction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results